Relationship of Hemoglobin A1C and Outcomes of Treatment of Diabetic Macular Edema
Journal Title: Ophthalmology Research: An International Journal - Year 2016, Vol 6, Issue 1
Abstract
Aims: To evaluate the relationship between Hemoglobin A1c (HbA1c) and visual and anatomical outcomes in eyes following treatment with intravitreal anti vascular endothelial growth factor (VEGF) agents and corticosteroids for diabetic macular edema (DME). Study Design: Retrospective observational case series. Place and Duration of Study: Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas between January 2012 and November 2014. Methodology: Case series from a single institution of 194 eyes from 134 consecutive patients with DME in the absence of concurrent retinal disease treated with at least 3 intravitreal injections of bevacizumab, ranibizumab, or aflibercept with at least 6 months of follow-up. Results: On multivariate analysis, initial HbA1c and initial BCVA were each associated to predict final visual outcome (p = 0.003 and p =0.001, respectively). Subgroup analysis demonstrated no statistical difference in improvement in mean BCVA (p=0.11) or mean CSMT (p=0.11) among patients whose hemoglobin A1c stayed stable, increased during the study or decreased during the study, however the mean number of injections required were respectively 6.5, 9.0 and 8.1 (p=0.02). Conclusions: The visual outcome following intravitreal bevacizumab, ranibizumab, or aflibercept with or without adjunctive triamcinolone acetonide are weakly related to glycemic control at initiation of treatment. Patients with stable glycemic control during treatment require fewer injections to treat diabetic macular edema compared to patients with improvement or worsening in glycemic control.
Authors and Affiliations
Robert B. Garoon, Lai Jiang, Petros E. Carvounis, Silvia Orengo-Nania, Robert E. Coffee
Keywords
Related Articles
- EP ID EP327605
- DOI 10.9734/OR/2016/28445
- Views 111
- Downloads 0
Genetic Predisposition to Advanced Retinopathy of Prematurity (ROP) Gains Support
Aims: The purpose of this short review is to summarize the recent developments in the genetics of retinopathy of prematurity. Background: Retinopathy of prematurity is a well known blinding disorder in children in both d...
Comparison of Phaco Energy and Complications for Conventional Phacoemulsification and 25-gauge Phacovitrectomy Surgery
Aim: To compare cumulative dissipated energy (CED), intraoperative and postoperative complications in eyes underwent conventional phacoemulsification and 25-Gauge phacovitrectomy surgery. Study Design: Retrospective, com...
A Systematic Review: What is the Normative Size of the Blind Spot Scotoma in Adults?
Background: Blind spot enlargement can be caused by a range of medical conditions and monitoring the size of the blind spot scotoma can indicate progression of disease. Objectives: The aim of this review is to establish...
Sudden Loss of Vision Associated with Use of Systemic Non-steroidal Anti-inflammatory Drugs
Non-steroidal anti inflammatory agents have long been used in ocular therapeutics as a result of their effect on infllammation coupled with the undesirable side effects of steroids in Ophthalmology. Bleeding peptic ulcer...
Measurement of Intraocular Pressure in a Porcine Ex Vivo Model Eye
Aims: To compare the pressure inside and outside the pig eye in relation to the location of cannulation for the injection of liquid into the anterior or vitreous chamber. Method: Eleven enucleated pig eyes were used. 46...